Published finding — does the expert body still believe it?
The EXTEND-IA trial's stated primary conclusion — CT-perfusion-selected thrombectomy produces early neurological improvement vs. tPA alone. — replicates in independent cohorts.
TL;DR · AI-generated
In patients with ischemic stroke with a proximal cerebral arterial occlusion and salvageable tissue on CT perfusion imaging, early thrombectomy with the Solitaire FR stent retriever, as compared with alteplase alone, improved reperfusion, early neurologic recovery, and functional outcome.
Your position — does this noeme still stand given current evidence?
0% (impossible)
50%
100% (certain)
Proper-scoring-rule preview
Your position is kept on this device until you sign in.
Evidence stream
2 events · 1 snapshot
posterior drift
71% → 71% (0pp · 1 point)
Registry data
Apr 18, 2026
Peer-reviewed paper
Apr 18, 2026
Expert reactions · 0
Sign in to post a take, cite a related claim, or flag a methodological concern.
No reactions yet. Be the first expert to post a take, cite a related claim, or flag a methodological concern.
Source publication
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
Bruce C.V. Campbell et al. · New England Journal of Medicine · 2015
· openalex W2119542322 · s2 958d215d
Semantically related
Nearest claims in the expert-corpus vector space. Ordered by cosine distance — lower is closer.
0.0869
The DEFUSE-3 trial's stated primary conclusion — Imaging-selected patients benefit from thrombectomy 6–16h after last-known-well. — replicates in independent cohorts.
0.0923
The REVASCAT trial's stated primary conclusion — Thrombectomy up to 8h after stroke onset is superior to medical therapy in selected patients. — replicates in independent cohorts.
0.0925
The MR CLEAN trial's stated primary conclusion — Endovascular thrombectomy within 6h improves functional outcome in proximal anterior circulation stroke. — replicates in independent cohorts.
0.0962
The SWIFT PRIME trial's stated primary conclusion — Stent-retriever thrombectomy plus tPA is superior to tPA alone for proximal anterior-circulation stroke. — replicates in independent cohorts.
0.0969
The ESCAPE trial's stated primary conclusion — Rapid endovascular treatment improves functional outcomes in proximal anterior-circulation stroke. — replicates in independent cohorts.
0.1022
The DAWN trial's stated primary conclusion — Mechanical thrombectomy benefits selected large-vessel-occlusion stroke patients in the 6–24h window. — replicates in independent cohorts.